The soluble mediators levels of ET and PMF patients were stratified according to their driver mutation status. ET JAK2V617F+ showed higher IL-6Ra levels than those with CALR mutation, and double negative (DN) for JAK2V617F and CALR. The gene discussed is CALR; the disease is essential thrombocythemia.